Skip to content
PICO Portalanswers from OpenAlex

Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy

PaperCitations, authors & open-access status

Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy is a paper indexed in PICO Portal from OpenAlex.

How many citations does Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy have?

PICO Portalcitation count

Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy has 368 citations in the OpenAlex counts PICO Portal stores.

When was Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy published?

PICO Portalyear

Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy has 2011 year in the PICO Portal index.

What is the open-access status of Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy?

PICO Portaloa status

Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy has bronze oa status in the PICO Portal index.

What is the DOI of Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy?

PICO Portaldoi

The DOI for Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy is on the source record.

What is the PMID of Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy?

PICO Portalpmid

The PMID for Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy is on the source record.

What is the OpenAlex record for Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy?

PICO Portalopenalex

The OpenAlex for Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial